1097909

Cefotaxime sodium

United States Pharmacopeia (USP) Reference Standard

• 동의어(들): Cefotaxime sodium salt, Cefotaxim sodium salt
• 실험식(Hill 표기법): C₁₆H₁₆N₅NaO₇S₂
• CAS Number: 64485-93-4
• Molecular Weight: 477.45
• Beilstein: 5711411
• MDL number: MFCD00079073
• UNSPSC 코드: 41116107
• PubChem Substance ID: 329749255
• NACRES: NA.24

속성

• Grade: pharmaceutical primary standard
• API family: cefotaxime
• 제조업체/상표: USP
• 응용 분야: pharmaceutical (small molecule)
• 형식: neat
• 저장 온도: 2-8°C
• SMILES string: [Na+].[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\c3csc(N)n3)C([O-])=O
• InChI: 1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m1./s1
• InChI key: AZZMGZXNTDTSME-JUZDKLSSSA-M

설명

일반 설명

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

애플리케이션

• Rapid evolutionary change in trait correlations of single proteins: This article explores the rapid evolutionary changes in protein traits, providing a fundamental understanding that can inform biochemical studies using tools like Cefotaxime sodium to influence protein interactions in bacterial cells, enhancing the effectiveness of antibacterial therapies (Dasmeh et al., 2024).


• Moringa oleifera as a potential antimicrobial against pathogenic Clostridium perfringens isolates in farm animals: Research investigates the antimicrobial properties of Moringa oleifera, with implications for enhancing the efficacy of antibiotic treatments like Cefotaxime sodium in combating bacterial infections in veterinary applications (Ibrahim and Altammar, 2024).


• In vitro antibacterial activity of antibiotics and plant essential oils against Escherichia coli MTCC443 supported through the molecular docking and pharmacokinetics study: This study examines the synergistic effects of Cefotaxime sodium with plant essential oils against E. coli, highlighting its potential in developing new antibacterial combinations that enhance drug efficacy and reduce resistance (Jain et al., 2024).


• Efficacy and safety of antibiotics for treatment of leptospirosis: a systematic review and network meta-analysis: This comprehensive review assesses the effectiveness of Cefotaxime sodium among other antibiotics in treating leptospirosis, offering critical insights into its clinical utility and safety profile (Ji et al., 2024).


• Changing Landscape of Antimicrobial Resistance in Neonatal Sepsis: An in silico Analyses of Multidrug Resistance in Klebsiella pneumoniae: The study discusses the rising challenge of antibiotic resistance, emphasizing the role of Cefotaxime sodium in treating complex cases of neonatal sepsis, thus underlining the need for continuous research into its mechanisms and resistance patterns (Vijayakumar et al., 2024).

생화학적/생리학적 작용

Cefotaxim inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. As a result, bacteria lyse due to cell wall autolytic enzymes.

Mode of Action: Inhibits bacterial cell wall synthesis.

기타 정보

Broad spectrum third generation cephalosporin antibiotic.

Sales restrictions may apply.

분석 메모

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

안전성 정보

• 픽토그램: GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H317,H334
• 예방조치 성명서: P261 - P280 - P284 - P304 + P340 - P342 + P311
• Hazard Classifications: Resp. Sens. 1 - Skin Sens. 1
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 2
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable